Corient Private Wealth LLC Sells 369 Shares of Universal Health Services, Inc. (NYSE:UHS)

Corient Private Wealth LLC lowered its holdings in Universal Health Services, Inc. (NYSE:UHS) by 1.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 28,454 shares of the health services provider’s stock after selling 369 shares during the period. Corient Private Wealth LLC’s holdings in Universal Health Services were worth $5,103,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also added to or reduced their stakes in the business. Envestnet Portfolio Solutions Inc. bought a new position in Universal Health Services in the fourth quarter valued at $564,000. Campbell Capital Management Inc. acquired a new stake in Universal Health Services in the fourth quarter valued at $46,000. First Eagle Investment Management LLC lifted its stake in Universal Health Services by 1.0% in the fourth quarter. First Eagle Investment Management LLC now owns 4,675,182 shares of the health services provider’s stock valued at $838,821,000 after acquiring an additional 44,099 shares during the last quarter. Skandinaviska Enskilda Banken AB publ lifted its stake in Universal Health Services by 39.0% in the fourth quarter. Skandinaviska Enskilda Banken AB publ now owns 40,926 shares of the health services provider’s stock valued at $7,300,000 after acquiring an additional 11,488 shares during the last quarter. Finally, Achmea Investment Management B.V. lifted its stake in Universal Health Services by 131.9% in the fourth quarter. Achmea Investment Management B.V. now owns 50,128 shares of the health services provider’s stock valued at $8,994,000 after acquiring an additional 28,509 shares during the last quarter. Institutional investors own 86.05% of the company’s stock.

Universal Health Services Price Performance

Shares of Universal Health Services stock opened at $174.49 on Friday. Universal Health Services, Inc. has a twelve month low of $152.69 and a twelve month high of $243.25. The company has a quick ratio of 1.28, a current ratio of 1.39 and a debt-to-equity ratio of 0.69. The company has a 50-day simple moving average of $181.84 and a two-hundred day simple moving average of $199.09. The stock has a market capitalization of $11.34 billion, a price-to-earnings ratio of 11.60, a price-to-earnings-growth ratio of 0.53 and a beta of 1.32.

Universal Health Services (NYSE:UHS) last issued its quarterly earnings data on Wednesday, February 26th. The health services provider reported $4.92 earnings per share for the quarter, topping the consensus estimate of $4.21 by $0.71. Universal Health Services had a net margin of 6.66% and a return on equity of 15.75%. The business had revenue of $4.11 billion during the quarter, compared to analysts’ expectations of $4.01 billion. Analysts forecast that Universal Health Services, Inc. will post 15.92 EPS for the current year.

Universal Health Services Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Monday, March 17th. Shareholders of record on Monday, March 3rd were paid a $0.20 dividend. This represents a $0.80 annualized dividend and a yield of 0.46%. The ex-dividend date of this dividend was Monday, March 3rd. Universal Health Services’s dividend payout ratio (DPR) is 4.75%.

Insiders Place Their Bets

In other Universal Health Services news, Director Maria Ruderman Singer sold 1,000 shares of the firm’s stock in a transaction dated Monday, March 10th. The shares were sold at an average price of $179.16, for a total value of $179,160.00. Following the transaction, the director now directly owns 7,916 shares of the company’s stock, valued at $1,418,230.56. This trade represents a 11.22 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 16.10% of the company’s stock.

Analysts Set New Price Targets

UHS has been the subject of a number of recent analyst reports. Wells Fargo & Company cut their price target on shares of Universal Health Services from $230.00 to $225.00 and set an “overweight” rating for the company in a research note on Monday, March 10th. JPMorgan Chase & Co. reiterated a “neutral” rating and issued a $226.00 price target on shares of Universal Health Services in a research note on Tuesday, December 17th. Stephens increased their price target on shares of Universal Health Services from $210.00 to $223.00 and gave the company an “equal weight” rating in a research note on Friday, February 28th. TD Cowen cut their target price on shares of Universal Health Services from $275.00 to $251.00 and set a “buy” rating for the company in a research note on Tuesday, November 26th. Finally, Barclays cut their target price on shares of Universal Health Services from $271.00 to $249.00 and set an “overweight” rating for the company in a research note on Thursday, February 27th. Six analysts have rated the stock with a hold rating, eight have assigned a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $230.75.

About Universal Health Services

Universal Health Services, Inc, through its subsidiaries, owns and operates acute care hospitals, and outpatient and behavioral health care facilities. It operates through Acute Care Hospital Services and Behavioral Health Care Services segments. The company's hospitals offer general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic and coronary care, pediatric services, pharmacy services, and/or behavioral health services.